Nanosponges: Novel Drug Delivery for Treatment of cancer by Santosh Kumar, Rada & Bhowmik, Ankana
Santosh Kumar et al                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):820-825 
ISSN: 2250-1177                                                                                  [820]                                                                                 CODEN (USA): JDDTAO 
Available online on 30.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                               Review Article 
Nanosponges: Novel Drug Delivery f or Treatment of cancer 
R. Santosh Kumar and Ankana Bhowmik 
GITAM Institute of Pharmacy, GITAM (Deemed To Be University) Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India. 
 
ABSTRACT 
The problems faced due to the conventional drug delivery system have been defeated after the invention of nanosponges (NS). NSs dru g 
delivery system is considered as the novel drug delivery system which has emerged as one of the most successful fields in life sciences. 
Nanosponges have been proved to be a boon in the treatment of cancer. Conventional drug delivery system, used in the treatment of cancer is 
generally insoluble and produces serious side effects. Thus, nanosponges are used in which the active drug is entrapped in a complex of 
polymers such as cyclodextrins. The drug is released from these nanoparticles to the specific targeted tumor sites and produce optimum 
therapeutic effect and minimal side effects. The nanosponges are generally biodegradable in nature. The solubility of the drug is increased due 
to which hydrophobic drugs can be incorporated within the NSs. The patient compliance is also improved due to this type of dr ug delivery 
system. Various factors which influence the drug delivery of NSs are the type of polymer used, type of drug incorporated, temperature, method 
of preparation and degree of substitution. The NSs are formulated by maintaining the above factors. The methods used are solvent method, 
melt technique, ultra-sound assisted synthesis, emulsion solvent diffusion method and loading the drug into the NSs. NSs are either crystalline 
or paracrystalline which have different loading capacities. This review mainly focuses on the nanosponges used as anticancer agents. The 
factors, method of formulation of the nanosponges are discussed in detail. 
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INTRODUCTION: 
Over the past few decades, there has been a rise in research 
of new drugs which has made health-care system expensive 
when compared to conventional drug delivery systems. 
Cancer treatment encountered major modifications due to 
the improved process of carcinogensis, cancer cell biology 
and tumor micro-environment. Despite of various clinical 
and pre-clinical researches, malignant tumors still remain 
fatal. Therefore, nanocarriers for anticancer drugs were 
developed to improve the survival of cancer patients. 
Most anticancer drugs are less water soluble and hence it 
results in multistep synthetic routes, which requires high 
specificity and selectivity. This can result in difficulty in 
development of formulations. Conventional techniques are 
not efficiently used in the delivery of atineoplastic agents, as 
it releases active ingredients inconveniently for a long period 
of time with short duration of action. It also induces acute 
adverse effects with toxic effects on active tissues. [1-3] 
Nanomedicines and nanotechnology is emerging in a rapid 
pace. The objectives in development of nanodrugs are both 
specific and nonspecific in targeting and delivery, better 
safety and biocompatibility with improved pharmacokinetic 
properties. Nanosponges produce controlled release of 
active ingredients to the predestined site, due to its smaller 
size and efficacious carrier characteristics. The nanoparticles 
release drug in a predictable fashion by adhereing to the 
surface of the tumor cells. Targeting the particle size of the 
system is the primary need in the tumor with large pore size, 
as tissue accumulation by enhanced permeability and 
retention (EPR) depends on extravasation of pores on highly 
permeable tumor vasculture. [4-7] 
Nanosponges (NSs) are prepared by using nanotechnology. 
These are made up of tiny particles with a narrow cavity 
measuring few nanometers. These tiny particles have the 
capability of carrying both hydrophillic and lipophillic drug 
substances and hence, it can increase the stability of poorly-
soluble drugs[8]. Nanosponges are three-dimensional scaffold 
with a network of polyester that is capable of degrading 
naturally. These are made of polyesters which are generally 
biodegradable, are mixed with a solution of cross-linkers. 
The polyester breaks down in the body. Once the scaffold is 
broken down, it releases the loaded drug molecule in a 
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derogatory fashion. As a result of this type of drug delivery, 
there is a reduce in side effects[9]. 
Nanoporous and mesoporous systems (organic or inorganic 
based NSs) have potential application in nanotherapeutics. 
Research prominence has been laid on organic systems, as 
inorganic systems leads to toxicity[10]. Cyclodextrin (CD) 
based NSs are used in cancer therapy[11]. An illustration of 
development and application of CD- based NSs is presented 
in this review. 
Various organic or inorganic materials such as silicon 
particle, titanium or other metal oxide and carbon coated 
metallic NSs are used in the formation of CD NSs. Initially CD 
NSs were used in water purification, as it can strongly bind 
to organic molecules in water and removes them at low 
concentrations. In the field of pharmaceuticals and 
biomedical sciences they are being used to increase 
solubility, bioavailability and stability, regulation of drug 
release, cosmetic conveyers and diagnostics.[12] 
Nanosponges have a nanosized cavity which belongs to 
hyper crosslinked polymer based colloidal solid 
nanoparticles. The average diameter of the NSs ranges upto 
1µm and fractions below 500nm can also be selected. They 
may be present in the form of crystalline or paracrystalline 
configuration depending on the loading capacities. Due to the 
presence of these unique properties NSs is considered as a 
drug of choice in delivery system for cancer therapy.
 
 
FIG.1: Action of cyclodextrin based nanosponge. 
ADVANTAGES OF NANOSPONGES: 
 Drug is released in a predictable fashion using 
nanosponges. 
 Relentless action up to 24hrs can be achieved. 
 The drug is encapsulated in the polymeric cage which 
provides sustained release and can withstand a 
temperature up to 300°C. 
 Provides enhanced stability and flexibility in 
formulation. 
 It has better solubility; hence, hydrophobic drugs can 
be entrapped within the NSs, after mixing with an 
adjuvant reagent. 
 NSs act as a self sterilizer as bacteria cannot penetrate 
into them because of their tiny pore size. 
 Side effects are minimized. 
 NS complexes are stable over a wide range of pH (1-11) 
and temperatures upto 130°C. 
 Converts liquids to powders, therefore, it offers higher 
degree of material processing. 
 Provides better patient compliance. 
 Used in masking the unpleasant flavour of the drug. 
 It has better stability, bioavailability and is also 
biodegradable. 
 Also used in topical delivery system. 
 Acts as a carrier for gases like oxygen and carbon 
dioxide, it carries oxygen to the hypoxic tissues. 
 The materials used provide barriers from premature 
destruction of the drug within the body. 
 It has the ability to link with the functional groups and 
hence enables drug delivery to the targeted site, it can 
be further enhanced by means of chemical linkers. 
 External magnetic field can also be applied for drug 
delivery to the targeted site by in-cooperating magnetic 
properties into NSs. 
 A milky colloidal suspension is produced in aqueous 
media, which is easy to regenerate by means of solvent 
extraction and thermal desorption using ultrasound. 
DISADANTAGES OF NANOSPONGES: 
 Not suitable for larger molecules, as NSs have the 
capacity to encapsulate only small molecules. 
 Dose dumping may occur occasionally. 
 May retard the release of drug. 
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FACTORS INFLUENCING DRUG DELIVERY BY 
NANOSPONGES: 
Type of Polymers Used: 
The performance of NSs depends on the polymer employed. 
The cavity size of NSs should be as such that it can 
accommodate the drug of a particular size.[13] 
 
FIG.2: Types of polymer used 
Type of Drugs: 
Drug molecules to be in-corporated with NSs should have the 
following characteristics: 
 Molecular weight should be in between 100 to 400 
Daltons. 
 Not more than five condensed rings should be present 
in the structure of the drug molecule. 
 Water solubility of the drug should be less than 10 
mg/ml 
 Melting point should not be more than 250°c [13]. 
Temperature: 
Changes in the temperature can affect the drug or the NS 
complexation. Generally , the magnitude of the apparent 
stability constant of the drug or NS decreases with increase 
in temperature, as a result of which there is possibility in 
reduction of drugs or NSs’ interaction forces such as Van-der 
waal forces and hydrophobic forces.[14] 
Method of Preparation: 
The drug/ nanosponge complexation can be affected 
depending on the method of preparation. However, 
effectiveness of a method depends on the nature of drug and 
polymer. Freeze drying was found to be most effective 
method for drug complexes in many cases.[14] 
Degree of Substitution: 
The type, number and position of the substituent on the 
parent molecules affects the complexation ability of the 
nanosponges.[14] 
METHODS OF PREPARATION: 
The methods used in the preparation of nanosponges are as 
follows: 
 Solvent method 
 Melt technique 
 Ultra-sound assisted synthesis 
 Emulsion solvent diffusion method 
 Loading of drug into nanosponges. 
1) Solvent Method: 
In this method, NSs can be obtained by mixing polymer with 
a suitable solvent like Dimethylformide (DMF), 
Dimethylsulfoxide (DMSO). Thereafter, the above mixture is 
added to the cross-linker in a molar ratio of 1:4. A 
temperature of 10°C to the reflux temperature of solution is 
maintained. The solution is then cooled to room 
temperature and transferred to bi-distilled water. Finally, 
the solution was filtered under vaccum with subsequent 
purification by prolonged soxhlet extraction with ethanol. 
The final product is obtained by drying under vaccum. The 
obtained size of nanosponges can be reduced by applying 
high-pressure homogenization at 4°C to avoid 
degradation.[12] 
2) Melt Technique: 
In this method, cyclo-dextrin is reacted with a cross-linker 
like dimetyl carbonate, di phenyl carbonate, di-isocyanates, 
di-aryl carbonates, carbonyl di-imidazole, carboxylic acid 
anhydrides and 2,2-bis (acrylamido) acetic acid. The above 
ingredients are homogenized and placed in a 250ml flask. It 
is then heated at 100°C and stirred using magnetic stirrer 
for 5hours. The mixture was then allowed to cool and the 
product was broken down. The final product was washed 
with suitable solvents to remove additional excipients and 
the by-products formed.[12] 
3) Ultra-Sound Assisted Synthesis: 
Nanosponges can be prepared by treating polymers with 
cross-linkers under sonication in the absence of solvent. In 
the above process, β-CD and diphenyl carbonate are 
combined together in a particular molar ratio, in a flask. 
This flask is then placed in an ultrasound bath filled with 
water and heated upto 90°C. It is sonicated for 5 hours. It is 
then allowed to cool down and the product is broken down 
abruptly. The final product was purified with water by 
soxhlet extraction with ethanol to remove the unreacted 
polymer. The obtained product was dried an stored at 
25°C.[15] 
4) Emulsion Solvent Diffusion Method: 
Different proportions of ethyl cellulose and polyvinyl 
alcohol are used. There are two phases; dispersed phase 
and continuous phase. In dispersed phase, ethyl cellulose 
and the drug is dissolved in 20ml of dichloromethane with 
addition of polyvinyl alcohol (PVA) to 150ml of continuous 
phase (aqueous). The mixture is then stirred at 1000 rpm 
for 2 hours. The mixture is filtered to collect the product. 
Eventually, the product is dried in an oven at a temperature 
of 400°C.[16] 
5) Loading Of Drug into Nanosponges: 
A nanosponge for drug delivery is pre-treated to a significant 
particle size below 500nm. Therefore, NSs are suspended in 
water and sonicated to avoid aggregates. The suspended 
solution undergoes centrifugation and the colloidal fraction 
is obtained. The resilient obtained is separated and the 
sample is freeze dried. The NS obtained is in aqueous 
suspension form which is dispersed in the excess amount of 
the drug and is stirred constantly until a complexation is 
formed. The uncomplexed drug form is separated by 
centrifugation. Further, the NSs are obtained in the form of 
solid crystals by solvent evapouration or by freeze drying. 
Crystal structure of NSs is much favoured in complexation 
with drug as the paracrystalline NSs show different loading 
capacities. The loading capacity for crystalline NSs is greater 
when compared to the paracrystalline NSs.[17] 
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FIG.3: Loading of drug into NSs. 
Nanosponges for Cancer Therapy: 
Anticancer drugs have low solubility; hence, it has become 
one of the most challenging works in the field of 
pharmaceutics. Nanosponges claim to be three times more 
effective in the reduction of growth of the tumor cells. The 
complexation of NS is loaded with a drug which is then 
exposed to the targeted peptide which is induced by a 
radiation, binds to the tumor receptor. The NS, bound to the 
tumor receptor starts releasing the drug molecules. This 
provides enhanced therapeutic effects with minimized 
adverse effects within the same dose. 
Nanosponges as Anti-Cancer Agents: 
1) CD- BASED NSs DRUG DELIVERY: 
Temozolomide: 
Phenyl carbonate based β-CD nanosponges was found to 
produce in-vitro toxicity which claimed Temozolomide to be 
a potential drug for the treatment of Glioma. It has been 
utilized as the 1st line therapy in the treatment o Gliomas 
after surgical resection. It requires intermittent dosing 
because of their short half-life of 1.8h and 15%of protein 
binding. Hence, Temozolomide has become successful in 
nanotechnology.[18] 
The structure of NSs can be estimated by using magnetic 
resonance spectroscopy. A slight shift in wavelength of the 
molecule showed interaction with hydrophobic groups; 
hence, the drug interaction was estimated. Fourier-
tranformation infrared radiation (FTIR), differential 
scanning calorimetry (DSC), and X-ray diffraction (XRD), was 
used in the embodiment and complexation inside the NS. The 
peaks obtained were either concealed or moved after NS 
formulation. NS based formulation of temozolomide showed 
sustained in-vitro release. It showed equivalent toxicity as 
that of free drug. The morphology of human giloblstoma 
astrocytoma of malignant tumor was deteriorated after the 
therapy. This formulation was further developed to produce 
potential delivery to the target site of the brain.[19] 
Paclitaxel: 
Chemotherapy is a complicated process. At times it may lead 
to toxicity; the non-specificity of anti-neoplastic drugs is the 
main reason for most of the effective drug being highly toxic. 
Due to the anticancer molecules, the occurrence of the side 
effects is much higher due to the poor water solubility of 
anticancer molecule. Paclitaxel is used in the treatment of 
small and non-small cell lung cancer, bladder cancer, neck 
and head cancer. It has low water solubility of 0.5mg/l and 
shows wide range of side effects. Various researches have 
been performed to modify paclitaxel by various methods 
such as emulsification, micellization, liposome formation, 
non- liposomal lipid carries and many others. A new 
formulation, albumin bound paclitaxel was developed for 
chemotherapy in the treatment of recurrent metastatic 
breast cancer. 
After many researches and development of nanosponges, 
paclitaxel was encapsulated in the nanosponge by combining 
cyclo-dextrins with diphenyl carbonate as cross-linker. A 
diameter of about 350nm with a drug payload of 500mg of 
paclitaxel/g of nanosponge was obtained. The evaluation of 
pharmacokinetic properties of paclitaxel NS was done via 
oral administration in rats. It showed a three-fold increase in 
bioavailability when compared to commercial taxol.[20] 
Resveratrol: 
Resveratrol is a natural, stilibenoid phenol. It is obtained 
from dietary sources like grapes, groundnuts, pistachios and 
blue-berries. It is an anti-oxidant and also has anti-oncogenic 
property. It has restricted half life and is digested at a faster 
rate followed by excretion. It has insignificant bioavailability 
when taken orally and may cause death blow. Therefore, its 
use is restricted for further use in clinical research. To 
overcome these limitations, nanotechnology has been 
developed. The NSs were used to enhance solubility, 
soundness and skin permeability of resveratrol. Different 
concentrations of cross-linkers (1:2 and 1:4; the molar 
premise of CD:CDI) were used. The solubility was increased 
by 33 to 48 times in F1:2 and F1:4 formulations when 
compared to the marketed drugs. Significant changes are the 
FTIR peaks were achieved by the action of resveratrol with 
NS. Release of the F1:4 formulations was much more uniform 
s compared to F1:2. The photostabiliy was aso improved. The 
skin permeation of resveratrol by NS formulation was much 
higher in pigs when compared to the skin permeation by 
hydroalcoholic mixtures. A two-fold mucosa acquisition in 
rabbit by resvertrol F1:4 was observed.[12] 
Curcumin: 
Curcumin is one of the most favourable anti-cancer agents. It 
is a hydrophobic polyphenolic phytochemical with low liquid 
solubility at acidic pH, whereas at basic pH it is highly 
soluble. It is a major constituent of turmeric. Apart from 
being a anticancer agent. It also acts as a neuroprotective, 
cardioprotective and antiathescleroti agent. It is used in the 
treatment of various types of tumors such as colon tumors, 
leukaemia, hepatic cellular carcinoma and prostate cancer. 
The cell proliferation and metastatis is inhibited and 
apoptosis is induced simultaneously by the action of 
curcumin on atomic nuclear factor –κB, tumor necrosis 
factor-α, interferon-Υ, interleukins, C-Jun N-terminal kinase, 
cyclo-oxygenases, protein kinase-C, nitrogen activated 
protein kinase, and many other reactos. Based on the 
pleiotropic properties, it was estimated that curcumin was 
more powerful than a solitary pathway therapy. Despite of 
its wide range of uses, curcumin has many disadvantages. It 
has low solubility, lower gastro intestinal absorption rate as 
well as lower bioavailability with significant metabolism. 
Degradation occurs at a physiological pH.[21] 
To overcome the above challenges in the formulation, Kurien 
et al. Developed β-CD NSs curcumin formulation; this proved 
to be an effective antineoplastic drug. Solubility of curcumin 
was enhanced to multiple times when compared to plain 
curcumin. This was because of the complexation of curcumin 
with NSs. Molecular size was around 487nm and 
performance index (PI) of 0.476 was achieved with a 
unimodal molecular size distribution within a narrow range. 
Zeta potential was about -27mV, this was sufficiently high for 
developing steady suspension. In an amorphous state, the 
drug can easily diffuse through the polymeric matrix of NSs 
producing a controlled release. The DSC was demonstrated 
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at 176°C, did not produce peak indicating the formation of 
inclusion complex. The sub-atomic structure of curcumin 
stays unaltered after its formulation. The formulation was 
found to be non- haemolytic upto a concentration of 
2mg/ml.[22] 
ETB Glutathione: 
One of the main causes for the cause for the cancer- related 
deaths is lung cancer, where chemotherapy is the only option 
for the treatment. Lung cancer is of two types; small cell lung 
cancer (SCLC) which comprises 15% of the cases and about 
85% of total cases comprises Non small cell lung cancer 
(NSCLC). Though chemotherapy is the only option, yet it 
produces undesired side-effects. Researches worked out and 
developed new targets for the treatment of various cancers 
by targeting epidermal growth factor receptor (EGFR). 
Erlotinib hydrochloric acid (ETB) was approved by USFDA 
for the treatment of NSCLC. Chemically, ETB is [6, 7-bis (2-
methoxy-ethoxy)-quinazolin-4-yl]-(-3-ethynylphenyl) amine 
hydrochloride which binds to human epidermal growth 
factor receptor by inhibiting tyrosine kinase. It inhibits 
angiogenisis by promoting cell cycle arrest and apoptosis. 
The cell is invaded by binding to the intracellular tyrosine 
kinase of EGFR, thus the receptor auto-phosphorylation is 
inhibited and downstream signal transduction is blocked. 
ETB glutathione is also used in the treatment of glioma, head 
and neck cancer and also ovarian cancer. 
There are some challenges which obstruct proper 
formulation of TB glutathione. Poor bioavailability due to its 
poor solubility is one of the reasons for the poor formulation 
of the drug. It is also unstable in gastro-intestinal 
environment. It produces toxic effects like severe skin rash, 
diarrhoeas and other haematological side effects. Therefore, 
to overcome these side effects, the therapeutic efficacy of the 
drug molecules is improved by encapsulating them within 
the internal cavity of nano-carriers. This process enhances 
the solubility, targeting efficacy and also the biocompatibility 
rate. Sustained release of the drug has also been achieved. 
ETB glutathione was incorporated into NSs by a single step 
reaction at room temperature. In-vitro release was evaluated 
by using high pressure liquid chromatography (HPLC). The 
NSs were a sphere shaped with a diameter of 212±245 nm 
and the loading capacity was around 92.34% ± 5.31% (p < 
0.001). In- vitro release of drug was much higher around 
76.89% ± 0.1% for duration of 168 hours; this was 
proportional to the concentration of ETB glutathione. 97.5% 
blockade in tumor cells was achieved by ETB glutathione NS 
when compared to plain ETB (48%). This proves that NSs 
directly targets the tumor site, thus preventing the drug 
exposure to other cells.[23] 
2) Delivery of Oxygen By NS Formulation Used In Cancer 
Therapy: 
Oxygen deficiency leads to hypoxia. The survival rate of the 
patients with hypoxic cervical malignant tumors is low. CD-
based NSs which were synthesised using alpha, beta or 
gamma carbonyl di-imidazole, has the capacity to store gases 
like oxygen and 1- methyl cyclopropene claims to play a 
promising role in cosmeceuticals, pharmaceuticals and 
biotechnology. The NS formulation to deliver oxygen, was 
combined with three different CDI based nanosponges i.e., 
alpha, beta and gamma. The suspension formed was 
homogenised using high shear rate for about 2-3 mins. 
Further, it was saturated with oxygen, sealed and stored at 
25°C to demonstrate the stability of NS. Vero cells were used 
to carry out the toxicity studies. A range between 40 and 
50m2/g was attained on the surface region of the NS. The 
molecular size of the circular NS was restricted to 400-
500nm. Negative zeta potential (-30mV) was obtained. This 
oxygen formulation did not show any toxicity. Agglomeration 
or degradation was not seen even at 25°C when stored for 15 
days. Oxygen penetration in β-CD NS was improved to above 
192% under the influence of ultra-sound which showed 
underlying oxygen spike. 
To eliminate the oxygen spike, a Pluronic® based hydrogel 
arrangement was used to produce a uniform release of 
oxygen. Trotta et al. Developed the O2 stacked NSs by 
including sodium chloride, PEG 400 and deca- fluoropentane. 
These compounds were blended along with NSs and water to 
enhance the stacking, stockpiling and delivery. Two 
formulations were developed; β-CD NSs and α-CD NSs. O2 
discharge was positively affected by ultrasound; 30% 
increase in the penetration rate of O2 from β-CD NSs 
formulation was achieved.[24,25] 
3) Water- Soluble and Sparingly Soluble Anti-Cancer 
Molecules: 
Doxorubicin: 
The first liposomal anticancer drug to get administrative 
approval was doxorubicin hydrochloride infusion. 
Doxorubicin is functional in the treatment of major organ 
tumors and delicate tissue cancers. It had certain 
disadvantages like cardiotoxicity and sharp action of 
doxorubicin, hence, nano-technology was proposed o 
decrease these effects. It was observed that doxorubicin was 
discharged in a moderate and uniform way after the 
incorporation into the nanosponges. The release of 
doxorubicin was pH dependent at an average rate of 1% in 
acidic pH over duration of 2 hours and about 29% release 
was observed in basic pH in 3 hours. Therefore, it can be 
estimated that doxorubicin was shielded by the NS in acidic 
media i.e., the stomach and then carried to the basic media, 
intestine and duodenum.[26,27] 
Flurouracil (5-FU): 
5-FU is the drug of choice in the treatment of colorectal 
cancer, stomach malignant tumors, and cervical malignant 
growth. When administered orally, it was poorly absorbed 
due to low solubility. It has low terminal half-life (8-20 mins) 
when administered parentally. The side effects produced 
were highly photosensitive when given intravenously. Thus, 
to improve the properties of this drug, gamma CD-based NSs 
were used. Direct compression method ws utilized in the 
preparation of 5-FU nanosponge. The excipients were 
combined homogenously and then commpressed into tablets 
of about 8mm. The invitro release of the drug was improved 
to 96.66%. Better solubility profiles were achieved. 
CONCLUSION: 
The nanosponge is a boon in cancer treatment and an 
effective drug delivery system for hydrophobic and 
lipophillic drugs. The efficacy in the formulation, maintaining 
stability of the drug has been increased due to the 
nanosponges. Thus, nanosponges is one of the most favoured 
drug delivery system and is a rising trend in pharmaceutical 
sciences for oral, topical and parenteral drug administration. 
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